PREDICTORS OF ONE-YEAR MORTALITY AFTER HEMODIALYSIS INITIATION: IMPACT OF ACUTE KIDNEY INJURY, HEART FAILURE AND MALIGNANCY
Abstract
Introdução: Hemodialysis (HD) is the most common form of kidney replacement therapy; however early mortality after initiation remains high. Identifying prognostic factors is essential for risk stratification and clinical decision-making. Objetivo: To assess one-year survival and identify factors associated with mortality in incident HD patients. Método: We conducted a retrospective observational study including all incident HD patients between January 2022 and December 2023. Clinical and demographic data were collected from medical records. One-year survival was assesseed using Kaplan–Meier analysis and Cox proportional hazards regression. Patients who recovered kidney function were censored at time of kidney recovery. Resultados: A total of 264 incident HD patients were included; 171 (64.8%) were male, and median age was 70.5 years (IQR 60–79). HD was initiated for end-stage kidney disease in 152 patients (57.6%) and for acute kidney injury (AKI) in 112 (42.4%); among the latter, 63 (56.3%) recovered kidney function. Previous nephrology follow-up was present in 161 patients (60.9%), and 204 patients (77.3%) initiated HD during hospitalization. Hypertension, diabetes, heart failure with reduced ejection fraction (HFrEF) and active malignancy were present in 86.7%, 43.9%, 17.0%, and 12.5% of patients, respectively. Among 201 patients who remained on dialysis, 152 (75.6%) were alive at one year. In multivariable analysis, older age (HR 1.049, 95% CI 1.015–1.084; p=0.005), AKI at HD initiation (HR 4.265, 95% CI 1.952–9.319; p<0.001), HFrEF (HR 2.053, 95% CI 1.009–4.175; p=0.047), and active malignancy (HR 7.139, 95% CI 2.847–17.903; p<0.001) were independently associated with increased mortality. AKI and active malignancy were the strongest predictors, conferring approximately four-fold and seven-fold higher mortality risks, respectively. Conclusão: One-year mortality after HD initiation remains substantial. AKI at initiation, active malignancy, and HFrEF are major independent predictors of poor prognosis, underscoring the importance of early risk stratification and individualized management at dialysis initiation.